Retatrutide

Identity & Classification

Class

Single-molecule triple incretin/glucagon receptor agonist

Research category

Metabolic Research

Range

New / Branded

Risk tier

Tier A

Full identity reference: Single-molecule triple incretin/glucagon receptor agonist. Investigational; not approved in any jurisdiction. CAS confirm from COA.

Mechanism Studied in Research

Simultaneous agonism of GLP-1R, GIPR, and glucagon receptor; studied in preclinical metabolic-signalling and energy-expenditure models.

Research Interest Areas

Incretin pharmacology, receptor co-agonism, energy-balance models.

Specifications

Form

Lyophilised solid

Kit total

10mg

Vial config

5mg x 2

QC

HPLC / MS Certificate of Analysis

Lead time

Confirmed at quote

Supply basis

Research use only · institution-verified

Source: 10mg kit, 5mg/vial x 2, lyophilised. Purity by HPLC/MS COA.

Storage & Handling

Reference material is supplied lyophilised in sealed vials. Recommended laboratory handling: store sealed vials at -20°C protected from light and moisture. Once reconstituted in a research-grade aqueous buffer, hold at 2–8°C for short-term use or aliquot and store at -20°C or below to limit freeze-thaw cycles. Allow vials to equilibrate to room temperature before opening to prevent condensation.

Reconstitution buffer, concentration, and assay format are determined by the receiving laboratory’s protocol. Syther Peptides does not supply usage protocols.

Quality & Compliance

Certificate of Analysis

Purity and identity are confirmed by Certificate of Analysis (HPLC / MS), available on request alongside the quote. The COA documents batch number, identity confirmation method, purity by HPLC peak-area, and reference to the analytical method used.

How to Enquire

1. STEP / 01
   Submit enquiry

   Provide institution, intended laboratory application, compound, quantity and format.

2. STEP / 02
   Research-gate check

   We confirm research-organisation context. Enquiries that cannot evidence one are declined.

3. STEP / 03
   Quote & COA

   Availability, lead time, and Certificate of Analysis returned within one business day.

FAQ

What is Retatrutide?

Retatrutide is an investigational triple-receptor agonist peptide (GLP-1 / GIP / glucagon) used as a reference compound in laboratory metabolic-signalling research. It is not approved for human use and is supplied for research use only.

What class of peptide is Retatrutide?

Retatrutide is described as: Single-molecule triple incretin/glucagon receptor agonist.

What pathway or receptor does Retatrutide act on?

Simultaneous agonism of GLP-1R, GIPR, and glucagon receptor; studied in preclinical metabolic-signalling and energy-expenditure models.

What is Retatrutide studied for in research?

Research interest areas include: Incretin pharmacology, receptor co-agonism, energy-balance models.

Is Retatrutide for human use?

No. Retatrutide is supplied for laboratory research use only and is not for human or veterinary consumption.

How is identity and purity of Retatrutide confirmed?

Identity and purity are confirmed by HPLC/MS Certificate of Analysis, supplied on request. Every vial carries a scratch-code that can be verified on this site.